Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00063895
What this trial is testing

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+27 more
National Cancer Institute (NCI) 80
Not applicableStudy completedNCT04634630
What this trial is testing

The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung

Who this might be right for
Lung Cancer, Nonsmall CellRelapse/RecurrenceCSC
Beatrice Aramini 35
Early research (Phase 1)Study completedNCT06799286
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bristol-Myers Squibb 10
Large-scale testing (Phase 3)Study completedNCT04248829
What this trial is testing

Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

Who this might be right for
Non-Small Cell Lung Cancer
Yuhan Corporation 393
Not applicableLooking for participantsNCT06598839
What this trial is testing

Immuno-effect of Tα1 for Stage I NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Yousheng Mao 40
Testing effectiveness (Phase 2)WithdrawnNCT05364645
What this trial is testing

Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8+2 more
SWOG Cancer Research Network
Early research (Phase 1)Study completedNCT03071757
What this trial is testing

The Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 139
Not applicableEnded earlyNCT00685750
What this trial is testing

Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 88
Early research (Phase 1)Study completedNCT05631678
What this trial is testing

Drug-drug Interaction Study Beteewn ASK120067 and Rifampicin or Itraconazole

Who this might be right for
Locally Advanced or Metastatic NSCLC
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 48
Early research (Phase 1)Study completedNCT06091943
What this trial is testing

Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
BeiGene 62
Early research (Phase 1)Study completedNCT00476216
What this trial is testing

Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerVenous Thromboembolism
University of Alabama at Birmingham 23
Early research (Phase 1)UnknownNCT05183243
What this trial is testing

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung CancerPancreatic Cancer+2 more
Suzhou Genhouse Bio Co., Ltd. 68
Testing effectiveness (Phase 2)Ended earlyNCT01646125
What this trial is testing

An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations

Who this might be right for
Advanced Non Small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals 59
Early research (Phase 1)Study completedNCT03894618
What this trial is testing

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more
Shattuck Labs, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT00036920
What this trial is testing

TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT06789224
What this trial is testing

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

Who this might be right for
Bladder CarcinomaProstate TumorGallbladder Carcinoma+9 more
Lindis Bloodcare GmbH 136
Testing effectiveness (Phase 2)UnknownNCT05435274
What this trial is testing

Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small-Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 380
Early research (Phase 1)Ended earlyNCT04990479
What this trial is testing

Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma

Who this might be right for
Melanoma (Skin)Non-Small-Cell Lung Carcinoma
Nouscom SRL 7
Testing effectiveness (Phase 2)Study completedNCT01829113
What this trial is testing

Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer

Who this might be right for
Non Squamous Non Small Cell Lung Cancer
SCRI Development Innovations, LLC 155
Testing effectiveness (Phase 2)UnknownNCT06065813
What this trial is testing

Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerNeoadjuvant TherapyRadiotherapy+1 more
Northern Jiangsu People's Hospital 20
Next Page